Gene · 84295
Papers1,520
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,520
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Appearances can be deceptive: acute myeloid leukaemia simulating chronic lymphocytic leukaemia. | Adv Lab Med | 2026 | 42713567 | PubTator, text mining | PubMed |
| Therapeutic targeting of tauopathies: From druggable biology to precision intervention. | Pharmacol Res | 2026 | 42697418 | PubTator, text mining | PubMed |
| Complex landscape of somatic copy number alterations in head and neck paragangliomas. | Front Endocrinol (Lausanne) | 2026 | 42666236 | PubTator, text mining | PubMed |
| Diagnostic delay in infants with very early-onset rare and ultra-rare genetic epilepsies. | Dev Med Child Neurol | 2026 | 42573089 | PubTator, text mining | PubMed |
| Ribosomal RNA transcription is regulated by sequestration of LATS2 and PHF6 to the nuclear speckles following DNA damage. | J Cell Sci | 2026 | 42421490 | PubTator, text mining | PubMed |
| Mixed phenotype acute leukemia: Lineage assignment, immunophenotypic classification and genetic insights. | Hum Pathol | 2026 | 42349662 | PubTator, text mining | PubMed |
| Disentangling Intrachain Folding from Interchain Assembly through Multidimensional Visualization. | J Phys Chem B | 2026 | 42316385 | PubTator, text mining | PubMed |
| Multiscale simulations reveal the driving forces underlying V337M-induced tau core fragment aggregation. | Nanoscale | 2026 | 42299954 | PubTator, text mining | PubMed |
| Tau profiling of brain extracellular vesicles reveals PHF6 peptide as core for pathological tau seeding in Alzheimer's disease. | J Biomed Sci | 2026 | 42298542 | PubTator, text mining | PubMed |
| [Correlation between Peripheral Blood Immunological Markers and Gene Mutations in Myelodysplastic Syndrome]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42227435 | PubTator, text mining | PubMed |
| Optical genome mapping uncovers disease-defining variants in an adult T-lymphoblastic leukemia and impacts prognosis. | Mol Cytogenet | 2026 | 42178565 | PubTator, text mining | PubMed |
| Putative Clonal Evolution in a PHF6-Mutant T/NK-Cell Lymphoproliferative Disorder With Selective Loss of a STAT5B-Mutant Subclone. | EJHaem | 2026 | 42093850 | PubTator, text mining | PubMed |
| Clinical Characteristics, Gene Mutation Profiles and Prognosis of Patients With Acute Myeloid Leukemia Carrying PHF6 Mutations. | Cancer Med | 2026 | 42087483 | PubTator, text mining | PubMed |
| α,β-Dehydroamino-Acid-Containing Peptides Resist Proteolysis and Inhibit Aggregation of a Tau-Derived Model Peptide. | J Org Chem | 2026 | 42048649 | PubTator, text mining | PubMed |
| Gradual N-terminal truncation of tau dGAE (297-391) reveals the importance of 321-325 sequence for early steps of fibril formation. | Int J Biol Macromol | 2026 | 42002168 | PubTator, text mining | PubMed |
| CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemia. | Blood Cancer J | 2026 | 41965730 | PubTator, text mining | PubMed |
| One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol. | Blood Cancer J | 2026 | 41935083 | PubTator, text mining | PubMed |
| Molecular variants, clonal evolution and clinical relevance in pediatric and adult T-cell lymphoblastic neoplasia. | Blood Cancer J | 2026 | 41927524 | PubTator, text mining | PubMed |
Correspondance: Venetoclax combined with FLAG-based chemotherapy induces rapid and deep responses in early T-cell precursor lymphoblastic leukemia/lymphoma. Report of two cases and review of the literature. | Ann Hematol | 2026 | 41925752 | PubTator, text mining | PubMed |
| Second allogeneic stem cell transplantation for XMEN disease. | BMJ Case Rep | 2026 | 41871900 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84295/papers